Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Dragana Šegulja"'
Autor:
Zrinka Sertić, Marko Lucijanić, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Božena Coha, Dražen Pulanić, Zinaida Perić, Lana Desnica, Mirta Mikulić, Marijo Vodanović, Ivo Radman-Livaja, Dragana Šegulja, Dunja Rogić, Toni Valković, Igor Aurer, Nadira Duraković
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2892 (2022)
Disease- and treatment-mediated immunodeficiency might render SARS-CoV-2 vaccines less effective in patients with hematologic diseases. We performed a prospective non-interventional study to evaluate humoral response after one and two doses of mRNA-1
Externí odkaz:
https://doaj.org/article/302bd8409cfa4283acb5a7c1a229e798
Autor:
Dragana Šegulja
Prisutnost M-proteina u serumu karakterizira stanje monoklonske gamapatije. Koncentracija M-proteina izravno korelira s veličinom tumorske mase, osim u vrlo rijetkim slučajevima nesekrecijske bolesti. Detekcija, tipizacija i kvantifikacija M-protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::3f6c1f2acfb14c242d1042ccaf21b508
https://www.bib.irb.hr/1269698
https://www.bib.irb.hr/1269698
Publikováno v:
Journal of Clinical Pathology. 75:782-786
This study aimed to determine antibody responses against SARS-CoV-2 spike (S) after both BioNTech–Pfizer Comirnaty vaccine doses and study the correlation with self-perceived adverse reactions. Antibodies determination with Elecsys anti-SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229477458e8024d185e00963feafca59
https://doi.org/10.1136/jclinpath-2021-207572
https://doi.org/10.1136/jclinpath-2021-207572
Autor:
Ivana Lapić, Dragana Šegulja, Kristina Dukić, Anamarija Bogić, Ana Lončar Vrančić, Sven Komljenović, Tajana Šparakl, Katarina Grdiša Teodorović, Vlasta Cigula Kurajica, Ivana Baršić Lapić, Saša Kralik Oguić, Ana Kozmar, Željka Vogrinc, Dunja Rogić
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 82(3)
The aim of this study was to perform the analytical validation of Alinity c and i analyzers (Abbott Laboratories, Chicago, IL, USA) for 39 clinical chemistry tests and 17 immunoassays. Precision was evaluated at least at two concentration levels for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7755bac5fa5e7fc04c445aa42e3cd2b
https://pubmed.ncbi.nlm.nih.gov/35373677
https://pubmed.ncbi.nlm.nih.gov/35373677
Autor:
Ivana Lapić, Dunja Rogić, Dragana Šegulja, Ana Kozmar, Marta Kmet, Lovorka Đerek, Renata Zadro
The present study aimed to clarify unusual total antibody kinetics in three female individuals observed during longitudinal monitoring of antibody response to BNT162b2 COVID-19 vaccine in 54 healthy volunteers. Total and IgG antibodies against the SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9241842da9c5def38f4d216e7447160b
https://www.bib.irb.hr/1219376
https://www.bib.irb.hr/1219376
Publikováno v:
Journal of Medical Virology
This study evaluates the correlation of salivary antibody response with antibody titers in blood of adult individuals vaccinated with BNT162b2 mRNA COVID-19 vaccine. Hereby we observed moderate correlation, which indicates that the presence of antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127066fe06ca062047aa94b0ce297647
https://doi.org/10.1002/jmv.27096
https://doi.org/10.1002/jmv.27096
Publikováno v:
Multiple Sclerosis and Related Disorders
Objective: The aim of this study is to determine a development of humoral response after COVID-19 vaccination in persons with secondary progressive multiple sclerosis (pwSPMS) on siponimod, compared to healthy controls (HC). Methods: In 13 pwSPMS tak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb087483fe965008b2b710d17c76dc84
http://europepmc.org/articles/PMC8629510
http://europepmc.org/articles/PMC8629510
Autor:
Mario Habek, Koraljka Đurić, Alenka Horvat Ledinek, Ivana Lapić, Tereza Gabelić, Nevena Grbić, Gregor Jakob Brecl, Dunja Rogić, Vanja Bašić Kes, Ivan Adamec, Magdalena Krbot Skorić, Andreja Emeršič, Dragana Šegulja, Barbara Barun
Publikováno v:
Journal of Neuroimmunology
Aim To determine the influence of high-efficacy disease modifying therapy (DMT) on the development of IgG SARS-CoV-2 antibody response in COVID-19 convalescent people with multiple sclerosis (pwMS). Methods Seventy-four pwMS taking high-efficacy DMTs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23727aafa3f2fce8621d988211ff9593
https://urn.nsk.hr/urn:nbn:hr:105:017413
https://urn.nsk.hr/urn:nbn:hr:105:017413
Autor:
Nadira Duraković, Bozena Coha, Dunja Rogić, Vlatka Periša, Ranka Serventi Seiwerth, Drazen Pulanic, Sandra Bašić-Kinda, Dragana Šegulja, Zrinka Sertić, Marko Lucijanic, Igor Aurer, Dubravka Sertić, Toni Valković
Publikováno v:
Blood
Background Patients with hematologic malignancy have a higher risk of death from COVID-19 compared to the general population. A blunted immune response from both the underlying disease and applied treatment may contribute to development of more sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b515936478836a1eb4772718c9ddd3
https://doi.org/10.1182/blood-2021-153573
https://doi.org/10.1182/blood-2021-153573
Case report - An unusually high plasma cobalamin in a male patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28349f50429804315b3143a2aaff9dee
https://doi.org/10.1093/clinchem/hvaa033
https://doi.org/10.1093/clinchem/hvaa033